Centella Asiatica Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

MEDITHERAPY is the best-performing centella asiatica brand in July 2026, moving 100,000 units across 1 ASIN for 28.7% of Top 10 volume. celimax follows with 100,000 units (28.7%), ahead of La Roche-Posay on 60,000 units (17.2%).

With 6 brands splitting the Top 10 and 74.7% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $16.88 to $18.97, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. On the growth side, B0FVG9NS7G leads positive momentum with ▲ 33.3% MoM growth on 4K units, with B0D9TX8G86 close behind at ▲ 25.0% MoM on 5K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.